Jane Street
MIST icon

Jane Street’s Milestone Pharmaceuticals MIST Stock Holding History

Jane Street’s Portfolio MIST Stock Details MIST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$41.8K Sell
31,200
-10,300
-25% -$16.5K ﹤0.01% 11002
2026
Q1 		$49.4K Sell
41,500
-37,400
-47% -$65.5K ﹤0.01% 10976
2025
Q4 		$159K Buy
+78,900
New +$170K ﹤0.01% 9888

Other funds holding MIST

PCM
Pavaki Capital Management Pueblo, Colorado $287M AUM
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
PBM
Propel Bio Management Los Angeles, California $191M AUM 102.42% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return
SAM
Simplify Asset Management Las Vegas, Nevada $7.19B AUM 6.88% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
KCM
Kalehua Capital Management Dallas, Texas $174M AUM
LPC
Lion Point Capital New York $20.9M AUM 195.52% 1-Year Est. Return

Jane Street's MIST Position: Q2 2026 in Review

Jane Street reduced its Milestone Pharmaceuticals (MIST) stake by 64% in Q2 2026, selling an estimated $163K and leaving 57,787 shares worth $77.4K. The position accounts for ﹤0.01% of the portfolio, ranked #10741.

Jane Street first reported a position in MIST in Q2 2025 and has held it in 5 quarters since. The position peaked at $2.21M in Q4 2025. 78 funds tracked by Wall St. Rank hold MIST as of Q2 2026.

  • Jane Street held 57,787 shares of Milestone Pharmaceuticals worth $77.4K as of Q2 2026.
  • Jane Street sold 101,882 Milestone Pharmaceuticals shares in Q2 2026, an estimated $163K.
  • Milestone Pharmaceuticals made up ﹤0.01% of Jane Street's portfolio in Q2 2026, its #10741 holding.
  • Jane Street first reported a position in Milestone Pharmaceuticals in Q2 2025 and has held it in 5 quarters since.
  • Jane Street's Milestone Pharmaceuticals position peaked at $2.21M in Q4 2025.
  • 78 funds tracked by Wall St. Rank held Milestone Pharmaceuticals as of Q2 2026.

Based on Jane Street's 13F filing for Q2 2026, filed 14 Aug 2026.